Iptacopan in Patients With ANCA Associated Vasculitis

NCT06388941 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis

Interventions

DRUG: Iptacopan
DRUG: Placebo
DRUG: Rituximab

Sponsor

Novartis Pharmaceuticals